Market Overview

UPDATE: BMO Capital Markets Downgrades Rexnord to Market Perform on Valuation

Related RXN
Updated Research Report on Rexnord - Analyst Blog
UPDATE: Barclays Initiates Coverage On Rexnord, Raises Estimates

BMO Capital Markets downgraded Rexnord (NYSE: RXN) from Outperform to Market Perform and maintained a $21.00 price target.

BMO Capital Markets commented, "We are downgrading Rexnord to Market Perform from Outperform as we believe the shares appear full valued amid mixed demand in the Water Management and Process & Motion Control end markets as well as weakness in Europe and Asia. … Several companies that compete with or are in markets similar to Rexnord expect either a weak or slow growth environment in 2013 in key end markets such as mining, motion control, and water & wastewater."

Rexnord closed at $20.33 on Wednesday.

Latest Ratings for RXN

DateFirmActionFromTo
Apr 2014Bank of AmericaDowngradesNeutralUnderperform
Jan 2014Credit SuisseUpgradesNeutralOutperform
Jul 2013Goldman SachsReinstatesNeutral

View More Analyst Ratings for RXN
View the Latest Analyst Ratings

Posted-In: BMO Capital MarketsAnalyst Color Downgrades Analyst Ratings

 

Related Articles (RXN)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters